Viking’s GLP-1 Pill Results Mixed, Shares Slump Viking Therapeutics, a US biotech company, recently faced a rollercoaster of reactions following the results of phase two trials of its much-anticipated GLP-1 pill. The pill, aimed at combating obesity, showed promising results with a weight loss of 12.2 percent among participants. However, the euphoria was dampened by […]
Ozempic-style obesity drug bypasses neurons, avoids nausea and vomiting side effects
Ozempic-Style Obesity Drug Bypasses Neurons, Avoids Nausea and Vomiting Side Effects Most weight loss and diabetes drugs on the market struggle to deliver lasting results. GLP-1 receptor agonists, a class of drugs including semaglutide (marketed as Ozempic), have shown great promise in tackling obesity and diabetes. However, these drugs often come with unpleasant side effects […]
Zepbound Beats Wegovy in First Head-to-Head Trial
Zepbound Triumphs Over Wegovy in Landmark Weight Loss Trial In the realm of weight loss medications, the competition is fierce, with pharmaceutical giants constantly vying to develop the most effective solutions for combating obesity. Recently, Eli Lilly’s GLP-1 drug Zepbound and Novo Nordisk’s Wegovy went head-to-head in a groundbreaking clinical trial to determine which medication […]
Novo Nordisk to Sell Wegovy Through Telehealth Firms
Novo Nordisk to Sell Wegovy Through Telehealth Firms In a strategic move to expand its market reach and streamline distribution, Novo Nordisk, a renowned pharmaceutical giant, has announced plans to collaborate with telehealth companies such as Hims & Hers and Ro. This partnership aims to facilitate the sale of Wegovy, one of Novo Nordisk’s groundbreaking […]
Eli Lilly’s New GLP-1 Pill Posts Better-Than-Expected Results
Eli Lilly’s New GLP-1 Pill Posts Better-Than-Expected Results Eli Lilly, a renowned pharmaceutical company, has recently made waves in the medical world with its groundbreaking GLP-1 pill, orforglipron. This experimental drug has surpassed all expectations by delivering exceptional results, particularly in terms of weight loss. In a remarkable turn of events, the highest dose of […]
Why the Obesity Drug Revolution Is a Work in Progress
The introduction of GLP-1 weight-loss drugs has transformed the landscape of obesity treatment, presenting an opportunity for millions seeking effective solutions. Drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are at the forefront of this revolution, promising significant health benefits and garnering billions in revenue for their manufacturers. However, as promising as they are, […]